Five pharma leaders appeared before Congress to discuss their COVID-19 vaccines. Lawmakers stressed the importance of making a vaccine safe, effective and accessible to all. (MM&M)

The pharma leaders also promised that the industry wasn’t cutting corners on vaccine development. Legislators were concerned about the speed at which pharma companies and the Food and Drug Administration were working to develop a vaccine. Pharma said both their companies and the FDA were following the usual safety protocols. (STAT)

Actual COVID-19 case counts could be as much as 24 times higher than reported, according to a report from the Centers for Disease Control and Prevention. The report estimated cases could be anywhere from six to 24 times higher than the confirmed number of cases based on antibody tests. (STAT)

Germany showed how important scientific communication is during the pandemic. Leaders like chancellor Angela Merkel and health minister Jens Spahn explained complex science to the public to help dispel misinformation, while scientists and virology experts became public figures. (CNBC)

Biogen to study Spinraza, in combination with Novartis gene therapy Zolgensma. The trial will test whether Spinraza improves outcomes in patients with spinal muscular atrophy who do not respond sufficiently to Zolgensma. It combines two of the most expensive drugs on the market. (Reuters)